Literature DB >> 12721930

How does herpes simplex virus type 2 influence human immunodeficiency virus infection and pathogenesis?

Anna Wald, Lawrence Corey.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12721930     DOI： 10.1086/374976

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  15 in total

Review 1.  Approaches to the control of sexually transmitted infections in developing countries: old problems and modern challenges.

Authors:  P Mayaud; D Mabey
Journal:  Sex Transm Infect       Date:  2004-06       Impact factor: 3.519

2.  Reducing Genital Herpes Transmission Using Antiviral Therapy.

Authors:  Noreen A. Hynes
Journal:  Curr Infect Dis Rep       Date:  2004-04       Impact factor: 3.725

3.  Genital herpes simplex virus type 2 infection in humanized HIV-transgenic mice triggers HIV shedding and is associated with greater neurological disease.

Authors:  Briana Nixon; Esra Fakioglu; Martha Stefanidou; Yanhua Wang; Monica Dutta; Harris Goldstein; Betsy C Herold
Journal:  J Infect Dis       Date:  2013-08-29       Impact factor: 5.226

4.  Aetiology of sexually transmitted infections and response to syndromic treatment in southwest Uganda.

Authors:  J M Pickering; J A G Whitworth; P Hughes; M Kasse; D Morgan; B Mayanja; L Van der Paal; P Mayaud
Journal:  Sex Transm Infect       Date:  2005-12       Impact factor: 3.519

5.  Comparative efficacy and immunogenicity of replication-defective, recombinant glycoprotein, and DNA vaccines for herpes simplex virus 2 infections in mice and guinea pigs.

Authors:  Yo Hoshino; Sarat K Dalai; Kening Wang; Lesley Pesnicak; Tsz Y Lau; David M Knipe; Jeffrey I Cohen; Stephen E Straus
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

6.  High seroprevalence of herpes simplex virus type 2 infection in French human immunodeficiency virus type 1-infected outpatients.

Authors:  Laurent Andréoletti; Emmanuel Piednoir; Jérôme Legoff; Véronique Brodard; Isabelle Beguinot; Christophe Strady; Christine Rouger; Christophe Piketty; Ali Si-Mohamed; Michel Daniel Kazatchkine; Jean-Elie Malkin; Laurent Bélec
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

7.  Effects of herpes simplex virus type 2 glycoprotein vaccines and CLDC adjuvant on genital herpes infection in the guinea pig.

Authors:  David I Bernstein; Julie D Earwood; Fernando J Bravo; Gary H Cohen; Roselyn J Eisenberg; Jennifer R Clark; Jeffrey Fairman; Rhonda D Cardin
Journal:  Vaccine       Date:  2011-01-14       Impact factor: 3.641

8.  HIV control in low-income countries in sub-Saharan Africa: are the right things done?

Authors:  Stefan Hanson; Claudia Hanson
Journal:  Glob Health Action       Date:  2008-10-09       Impact factor: 2.640

9.  Potent adjuvant activity of cationic liposome-DNA complexes for genital herpes vaccines.

Authors:  David I Bernstein; Rhonda D Cardin; Fernando J Bravo; Jane E Strasser; Nicholas Farley; Claudia Chalk; Marla Lay; Jeff Fairman
Journal:  Clin Vaccine Immunol       Date:  2009-03-11

10.  Seroprevalence and factors associated with herpes simplex virus type 2 among HIV-negative high-risk men who have sex with men from Rio de Janeiro, Brazil: a cross-sectional study.

Authors:  Junia Rodrigues; Beatriz Grinsztejn; Francisco I Bastos; Luciane Velasque; Paula M Luz; Claudia T V de Souza; Ingebourg Georg; Jose H Pilotto; Valdilea G Veloso
Journal:  BMC Infect Dis       Date:  2009-04-01       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.